Randomized, three- way, three- period, single oral dose, open-label, crossover, bioequivalence study to compare Lorvast Tablets /Tabuk Pharmaceutical Mfg. Co. (20 mg Atorvastatin), versus Lipitor® (20 mg Atorvastatin) Produced by Pfizer in healthy subjects under fasting conditions.

drug protocol number
42370
drug sponsor
SFDA
drug study
Lipitor® lovarst tablet
drug trial site
saudi Ajal
drug status
Completed
drug phase